Cargando…
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Gene fusions can drive tumor development for multiple types of cancer. Currently, many drugs targeting gene fusions are being approved for clinical application. At present, tyrosine receptor kinase (TRK) inhibitors targeting neurotrophic tyrosine receptor kinase (NTRK) gene fusions are among the fir...
Ejemplares similares
-
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
por: Wang, Wenxian, et al.
Publicado: (2022) -
Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer
por: Zhang, Shirong, et al.
Publicado: (2022) -
Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China
por: Pu, Xingxiang, et al.
Publicado: (2023) -
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
por: Wang, Qian, et al.
Publicado: (2023) -
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
por: Xu, Chunwei, et al.
Publicado: (2023)